Synaptic elimination and the complement system in
Yüklə 496,14 Kb. Pdf görüntüsü
|
- Bu səhifədəki naviqasiya:
- Document Outline
Synaptic elimination and the complement system in Alzheimer’s disease 52
Sano M, Schneider LS, Seeley W, Shelanski ML, Slifer MA, Smith CD, Sonnen JA, Spina S, Stern RA, Tanzi RE, Trojanowski JQ, Troncoso JC, Van Deerlin VM, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Williamson J, Woltjer RL, Cantwell LB, Dombroski BA, Beekly D, Lunetta KL, Martin ER, Kamboh MI, Saykin AJ, Reiman EM, Bennett DA, Morris JC, Montine TJ, Goate AM, Blacker D, Tsuang DW, Hakonarson H, Kukull WA, Foroud TM, Haines JL, Mayeux R, Pericak-Vance MA, Farrer LA, Schellenberg GD (2011) Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nature genetics 43 (5):436-441. Neher E, Sakmann B (1976) Single-channel currents recorded from membrane of denervated frog muscle fibres. Nature 260 (5554):799- 802.
O'Brien RJ, Resnick SM, Zonderman AB, Ferrucci L, Crain BJ, Pletnikova O, Rudow G, Iacono D, Riudavets MA, Driscoll I, Price DL, Martin LJ, Troncoso JC (2009) Neuropathologic studies of the Baltimore Longitudinal Study of Aging (BLSA). Journal of Alzheimer's disease : JAD 18 (3):665-675. O'Connor TP, Cockburn K, Wang W, Tapia L, Currie E, Bamji SX (2009) Semaphorin 5B mediates synapse elimination in hippocampal neurons. Neural development 4:18. Origlia N, Capsoni S, Cattaneo A, Fang F, Arancio O, Yan SD, Domenici L (2009) Abeta-dependent Inhibition of LTP in different intracortical circuits of the visual cortex: the role of RAGE. Journal of Alzheimer's disease : JAD 17 (1):59-68. Origlia N, Righi M, Capsoni S, Cattaneo A, Fang F, Stern DM, Chen JX, Schmidt AM, Arancio O, Yan SD, Domenici L (2008) Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta- mediated cortical synaptic dysfunction. The Journal of neuroscience : the official journal of the Society for Neuroscience 28 (13):3521- 3530. Osawa M, Yamamoto Y, Munesue S, Murakami N, Sakurai S, Watanabe T, Yonekura H, Uchigata Y, Iwamoto Y, Yamamoto H (2007) De-N- glycosylation or G82S mutation of RAGE sensitizes its interaction with advanced glycation endproducts. Biochim Biophys Acta 1770 (10):1468-1474. Otto T, Poon P (2006) Dorsal hippocampal contributions to unimodal contextual conditioning. The Journal of neuroscience : the official journal of the Society for Neuroscience 26 (24):6603-6609. Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, Giustetto M, Ferreira TA, Guiducci E, Dumas L, Ragozzino D, Gross CT (2011) Synaptic pruning by microglia is necessary for normal brain development. Science 333 (6048):1456-1458.
53
Parkin ET, Watt NT, Hussain I, Eckman EA, Eckman CB, Manson JC, Baybutt HN, Turner AJ, Hooper NM (2007) Cellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein. Proceedings of the National Academy of Sciences of the United States of America 104 (26):11062-11067. Peineau S, Taghibiglou C, Bradley C, Wong TP, Liu L, Lu J, Lo E, Wu D, Saule E, Bouschet T, Matthews P, Isaac JT, Bortolotto ZA, Wang YT, Collingridge GL (2007) LTP inhibits LTD in the hippocampus via regulation of GSK3beta. Neuron 53 (5):703-717. Pekna M, Hietala MA, Rosklint T, Betsholtz C, Pekny M (1998) Targeted disruption of the murine gene coding for the third complement component (C3). Scandinavian journal of immunology 47 (1):25-29. Penzes P, Cahill ME, Jones KA, VanLeeuwen JE, Woolfrey KM (2011) Dendritic spine pathology in neuropsychiatric disorders. Nature neuroscience 14 (3):285-293. Perry VH, O'Connor V (2008) C1q: the perfect complement for a synaptic feast? Nature reviews Neuroscience 9 (11):807-811. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342 (8873):697-699. Pozueta J, Lefort R, Shelanski M (2012) Synaptic changes in Alzheimer's disease and its models. Neuroscience. Priller C, Bauer T, Mitteregger G, Krebs B, Kretzschmar HA, Herms J (2006) Synapse formation and function is modulated by the amyloid precursor protein. The Journal of neuroscience : the official journal of the Society for Neuroscience 26 (27):7212-7221. Qu J, Nakamura T, Cao G, Holland EA, McKercher SR, Lipton SA (2011) S- Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide. Proceedings of the National Academy of Sciences of the United States of America 108 (34):14330-14335. Reitz C, Brayne C, Mayeux R (2011) Epidemiology of Alzheimer disease. Nature reviews Neurology 7 (3):137-152. Ringman JM, Schulman H, Becker C, Jones T, Bai Y, Immermann F, Cole G, Sokolow S, Gylys K, Geschwind DH, Cummings JL, Wan HI (2012) Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutations. Archives of neurology 69 (1):96-104. Salmon DP, Bondi MW (2009) Neuropsychological assessment of dementia. Annu Rev Psychol 60:257-282. Sarma JV, Ward PA (2011) The complement system. Cell and tissue research 343 (1):227-235. Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki R, Ransohoff RM, Greenberg ME, Barres BA, Stevens B Synaptic elimination and the complement system in Alzheimer’s disease 54
(2012) Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 74 (4):691-705. Scheff SW, Price DA (2003) Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies. Neurobiology of aging 24 (8):1029- 1046. Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, Bis JC, Smith AV, Carassquillo MM, Lambert JC, Harold D, Schrijvers EM, Ramirez-Lorca R, Debette S, Longstreth WT, Jr., Janssens AC, Pankratz VS, Dartigues JF, Hollingworth P, Aspelund T, Hernandez I, Beiser A, Kuller LH, Koudstaal PJ, Dickson DW, Tzourio C, Abraham R, Antunez C, Du Y, Rotter JI, Aulchenko YS, Harris TB, Petersen RC, Berr C, Owen MJ, Lopez-Arrieta J, Varadarajan BN, Becker JT, Rivadeneira F, Nalls MA, Graff- Radford NR, Campion D, Auerbach S, Rice K, Hofman A, Jonsson PV, Schmidt H, Lathrop M, Mosley TH, Au R, Psaty BM, Uitterlinden AG, Farrer LA, Lumley T, Ruiz A, Williams J, Amouyel P, Younkin SG, Wolf PA, Launer LJ, Lopez OL, van Duijn CM, Breteler MM (2010) Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA : the journal of the American Medical Association 303 (18):1832-1840. Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL (2007) Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. The Journal of neuroscience : the official journal of the Society for Neuroscience 27 (11):2866-2875. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14 (8):837-842. Shinoda Y, Kamikubo Y, Egashira Y, Tominaga-Yoshino K, Ogura A (2005) Repetition of mGluR-dependent LTD causes slowly developing persistent reduction in synaptic strength accompanied by synapse elimination. Brain research 1042 (1):99-107. Shipton OA, Leitz JR, Dworzak J, Acton CE, Tunbridge EM, Denk F, Dawson HN, Vitek MP, Wade-Martins R, Paulsen O, Vargas- Caballero M (2011) Tau protein is required for amyloid {beta}- induced impairment of hippocampal long-term potentiation. The Journal of neuroscience : the official journal of the Society for Neuroscience 31 (5):1688-1692. Shrestha BR, Vitolo OV, Joshi P, Lordkipanidze T, Shelanski M, Dunaevsky A (2006) Amyloid beta peptide adversely affects spine number and motility in hippocampal neurons. Molecular and cellular neurosciences 33 (3):274-282.
55
Smith DL, Pozueta J, Gong B, Arancio O, Shelanski M (2009) Reversal of long-term dendritic spine alterations in Alzheimer disease models. Proceedings of the National Academy of Sciences of the United States of America 106 (39):16877-16882. Spitzer RL, Williams JBW, American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders : DSM-III-R. 3. edn. The Assoc. ; Press syndicate of the Univ., Washington Cambridge. Squire LR (2008) Fundamental neuroscience. 3rd edn. Elsevier / Academic Press, Amsterdam ; Boston. Squire LR, Wixted JT (2011) The cognitive neuroscience of human memory since H.M. Annual review of neuroscience 34:259-288. Stephan AH, Barres BA, Stevens B (2012) The complement system: an unexpected role in synaptic pruning during development and disease. Annual review of neuroscience 35:369-389. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, Micheva KD, Mehalow AK, Huberman AD, Stafford B, Sher A, Litke AM, Lambris JD, Smith SJ, John SW, Barres BA (2007) The classical complement cascade mediates CNS synapse elimination. Cell 131 (6):1164-1178. Stys PK, You H, Zamponi GW (2012) Copper-dependent regulation of NMDA receptors by cellular prion protein: implications for neurodegenerative disorders. The Journal of physiology 590 (Pt 6):1357-1368. Sun C, Zhao M, Li X (2012) CFB/C2 Gene Polymorphisms and Risk of Age- Related Macular Degeneration: A Systematic Review and Meta- Analysis. Current eye research 37 (4):259-271. Tada T, Sheng M (2006) Molecular mechanisms of dendritic spine morphogenesis. Current opinion in neurobiology 16 (1):95-101. Takashima A, Noguchi K, Michel G, Mercken M, Hoshi M, Ishiguro K, Imahori K (1996) Exposure of rat hippocampal neurons to amyloid beta peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3 beta. Neuroscience letters 203 (1):33-36. Terauchi A, Johnson-Venkatesh EM, Toth AB, Javed D, Sutton MA, Umemori H (2010) Distinct FGFs promote differentiation of excitatory and inhibitory synapses. Nature 465 (7299):783-787. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Annals of neurology 30 (4):572-580. Tombaugh TN, McIntyre NJ (1992) The mini-mental state examination: a comprehensive review. Journal of the American Geriatrics Society 40 (9):922-935. Synaptic elimination and the complement system in Alzheimer’s disease 56
Townsend M, Mehta T, Selkoe DJ (2007) Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway. J Biol Chem 282 (46):33305-33312. Turrigiano GG (2008) The self-tuning neuron: synaptic scaling of excitatory synapses. Cell 135 (3):422-435. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416 (6880):535-539. Wang J, Ohno-Matsui K, Yoshida T, Shimada N, Ichinose S, Sato T, Mochizuki M, Morita I (2009) Amyloid-beta up-regulates complement factor B in retinal pigment epithelial cells through cytokines released from recruited macrophages/microglia: Another mechanism of complement activation in age-related macular degeneration. Journal of cellular physiology 220 (1):119-128. Wang Q, Walsh DM, Rowan MJ, Selkoe DJ, Anwyl R (2004) Block of long- term potentiation by naturally secreted and synthetic amyloid beta- peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5. The Journal of neuroscience : the official journal of the Society for Neuroscience 24 (13):3370-3378. Wang Y, Hancock AM, Bradner J, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Edwards KL, Snapinn KW, Goldstein DS, Shi M, Zhang J (2011) Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy. The American journal of pathology 178 (4):1509-1516. Wasling P, Daborg J, Riebe I, Andersson M, Portelius E, Blennow K, Hanse E, Zetterberg H (2009) Synaptic retrogenesis and amyloid-beta in Alzheimer's disease. Journal of Alzheimer's disease : JAD 16 (1):1- 14. Wasling P, Hanse E, Gustafsson B (2004) Developmental changes in release properties of the CA3-CA1 glutamate synapse in rat hippocampus. Journal of neurophysiology 92 (5):2714-2724. Veerhuis R, Nielsen HM, Tenner AJ (2011) Complement in the brain. Molecular immunology 48 (14):1592-1603. White L (2009) Brain lesions at autopsy in older Japanese-American men as related to cognitive impairment and dementia in the final years of life: a summary report from the Honolulu-Asia aging study. Journal of Alzheimer's disease : JAD 18 (3):713-725. Victoroff J, Mack WJ, Lyness SA, Chui HC (1995) Multicenter clinicopathological correlation in dementia. The American journal of psychiatry 152 (10):1476-1484.
57
Wigstrom H, Gustafsson B (1986) Postsynaptic control of hippocampal long- term potentiation. Journal de physiologie 81 (4):228-236. Wills ZP, Mandel-Brehm C, Mardinly AR, McCord AE, Giger RJ, Greenberg ME (2012) The nogo receptor family restricts synapse number in the developing hippocampus. Neuron 73 (3):466-481. Wilson RS, Mendes De Leon CF, Barnes LL, Schneider JA, Bienias JL, Evans DA, Bennett DA (2002) Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA : the journal of the American Medical Association 287 (6):742-748. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC (2004) Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of internal medicine 256 (3):240-246. Vitolo OV, Sant'Angelo A, Costanzo V, Battaglia F, Arancio O, Shelanski M (2002) Amyloid beta -peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proceedings of the National Academy of Sciences of the United States of America 99 (20):13217-13221. Vitureira N, Letellier M, Goda Y (2011) Homeostatic synaptic plasticity: from single synapses to neural circuits. Current opinion in neurobiology. Wong CW, Quaranta V, Glenner GG (1985) Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related. Proceedings of the National Academy of Sciences of the United States of America 82 (24):8729-8732. Yang CH, Huang CC, Hsu KS (2005) Behavioral stress enhances hippocampal CA1 long-term depression through the blockade of the glutamate uptake. The Journal of neuroscience : the official journal of the Society for Neuroscience 25 (17):4288-4293. Yasojima K, Schwab C, McGeer EG, McGeer PL (1999) Up-regulated production and activation of the complement system in Alzheimer's disease brain. The American journal of pathology 154 (3):927-936. You H, Tsutsui S, Hameed S, Kannanayakal TJ, Chen L, Xia P, Engbers JD, Lipton SA, Stys PK, Zamponi GW (2012) Abeta neurotoxicity depends on interactions between copper ions, prion protein, and N- methyl-D-aspartate receptors. Proceedings of the National Academy of Sciences of the United States of America 109 (5):1737-1742. Zecevic N, Rakic P (1991) Synaptogenesis in monkey somatosensory cortex. Cereb Cortex 1 (6):510-523. Zetterberg M, Landgren S, Andersson ME, Palmer MS, Gustafson DR, Skoog I, Minthon L, Thelle DS, Wallin A, Bogdanovic N, Andreasen
Synaptic elimination and the complement system in Alzheimer’s disease 58
N, Blennow K, Zetterberg H (2008) Association of complement factor H Y402H gene polymorphism with Alzheimer's disease. American journal of medical genetics Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 147B (6):720-726. Zhao D, Watson JB, Xie CW (2004) Amyloid beta prevents activation of calcium/calmodulin-dependent protein kinase II and AMPA receptor phosphorylation during hippocampal long-term potentiation. Journal of neurophysiology 92 (5):2853-2858. Zucker RS, Regehr WG (2002) Short-term synaptic plasticity. Annual review of physiology 64:355-405.
Document Outline
Yüklə 496,14 Kb. Dostları ilə paylaş:
|